<a href="https://www.bioagilytix.com/blog/category/immunogenicity/">Immunogenicity</a>
Immunogenicity Testing For Biosimilars
Entering the biosimilars market is an enticing prospect for many biopharma companies, offering the potential for reduced development and manufacturing costs while providing patients with…
<a href="https://www.bioagilytix.com/blog/category/biosimilars/">Biosimilars</a>
The State Of The Biosimilars Market
3 key challenges facing the biosimilars space in 2023 In 2010, the biopharma industry saw an abrupt patent cliff: a significant number of top-selling drugs…
<a href="https://www.bioagilytix.com/blog/category/biomarkers/">Biomarkers</a>
Difference Between Biobetters and Biosimilars
According to research compiled by Reports and Data, in 2018 the global biologics market was valued at over $250 million, but is projected to reach…
<a href="https://www.bioagilytix.com/blog/category/bioagilytix-insight/">BioAgilytix Insight</a>
Bioanalytical Strategies to Support Biosimilar Programs: How BioAgilytix is Helping to Shape Best Practices
BioAgilytix has been fortunate enough to have several of our team members participate as co-authors on all three AAPS white papers in the series on…